Skip to main content
ACH logo

ACH · Accendra Health Inc · Investor Relations

Track ACH — free
$0.02 0.00 (-3.50%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$6.59M
Shares
76.92M
Volume · Nov 18 17.62M Avg daily vol (3M) 2.97M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-05 Accendra Health Reports Third Quarter 2026 Financial Results
2026-11-02 Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
2026-10-30 Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard​
2026-10-22 Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
2026-10-09 Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
2026-09-17 Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
2026-08-17 Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
2026-08-10 Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
2026-08-10 Accendra Health Reports Second Quarter 2026 Financial Results
2026-08-10 Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
2026-07-27 Accendra Health Announces Leadership Appointments in IT and Procurement
2026-07-27 Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
2026-06-24 Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
2026-06-10 Accendra Health Announces Early Results of Offers and Consent Solicitations
2026-05-22 Accendra Health Announces Offers and Consent Solicitations
2026-05-11 Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
2026-05-01 Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
2026-02-19 Accendra Health Reports Fourth Quarter 2025 Financial Results
2026-02-05 Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
2026-01-02 Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”
2025-12-31 Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
2025-12-18 Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.
2025-12-02 Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

Past events

Source: https://investors.accendrahealth.com/home/default.aspx

Key facts CIK 75252 CUSIP 690732102 13F (30d) 147 filings 111 filers Visit website Investor relations